HDHongbin Deng

Hongbin Deng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongbin Deng has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Weiqin Li

    Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

    2 shared publications
  • Chunmei Xu

    Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China

    1 shared publication
  • Chunyu Zeng

    Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China

    1 shared publication
  • Dandong Fang

    Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, China

    1 shared publication
  • Daqian Gu

    Department of Cardiology, Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China

    1 shared publication
  • Daqian Gu

    Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, China

    1 shared publication

Latest Publications

  • Open Access

    Beyond the Muscle–Kidney Paradigm: Liver–Muscle–Kidney Interactions in Rhabdomyolysis

    by Xiangyi Zhou, Hongbing Deng, Fachun Zhou, Zhihui Tong, Daqian Gu

    Rhabdomyolysis is classically understood as skeletal muscle injury complicated by myoglobin-mediated acute kidney injury, but this framework does not fully explain the diagnostic and clinical complexity created by liver disease, aminotransferase abnormalities, and multiorgan dysfunction. This narrative review summarizes clinical and experimental evidence on liver, muscle, and kidney interactions in rhabdomyolysis. Relevant studies addressing aminotransferase elevation, liver-related susceptibility to muscle injury, rhabdomyolysis-associated kidney injury, interorgan communication, and shared systemic insults were reviewed. The evidence indicates that aminotransferase elevation in rhabdomyolysis often reflects muscle injury rather than primary hepatic damage, requiring interpretation with serial enzyme trends, liver-specific markers, and clinical context. Liver disease may increase vulnerability to muscle injury and kidney injury through sarcopenia, metabolic disturbance, altered drug handling, and impaired perfusion. Severe rhabdomyolysis may also contribute to hepatic stress through inflammation, heme-related pathways, and AKI-mediated effects, although direct causal evidence remains limited. A liver–muscle–kidney framework may improve integrated assessment, but prospective studies are needed to clarify temporal relationships and validate clinically useful biomarkers.

  • Open Access

    Lactobacillus rhamnosus GG Alleviates Post-Weaning Stress-Induced Intestinal Barrier Damage and Inflammation by Promoting Intestinal Health and Modulating the Gut Microbiota in Piglets

    by Gaohuan Hou, Hongbin Deng, Lingliang Zhou, Yang Liu, Weiqin Li, Weifen Li, Qi Wang

    The aim of this study is to investigate oral administration of L. rhamnosus GG (LGG) in early life on the growth performance, diarrhea, intestinal health, and microbiota of post-weaning piglets. Ninety-six newborn piglets were randomly divided into two groups. Piglets were orally administered with 2 mL of 10% sterile skim milk or 2 mL of 10% sterile skim milk suspended with viable LGG (1 × 108 CFU/mL). Results showed that compared with the control group, oral administration of LGG in early life slightly decreased diarrhea incidence. Furthermore, LGG supplementation maintained the intestinal barrier integrity (HE, DAO) and reduced the generation of the inflammatory response. 16S rRNA sequencing showed that LGG modulated the colon microbiota composition of piglets by increasing the relative abundance of Bifidobacterium, Helicobacter, Mucispirillum, and Dorea. Metabolomic study suggested that LGG substantially influenced the intestinal metabolic profile, particularly compounds associated with the biosynthesis of unsaturated fatty acids. The metabolic alterations were closely linked to the enhancement of the microbial community makeup. The analysis of jejunum RNA sequencing indicated that, in comparison to the CON group, LGG significantly downregulated various immune-related signaling pathways, especially the PI3K/AKT pathways. Correlation analysis of microbiota, metabolism, and genes uncovered a substantial association between the taxa enhanced by LGG and the critical genes in the PI3K/AKT signaling pathways. The coculture system of LGG and intestinal organoids revealed that LGG alleviated TNF-α induced injury through inhibiting the PI3K/AKT signaling pathway. Overall, the integrated analysis of multiple omics approaches revealed that LGG reduced post-weaning induced intestinal injury through the regulation of gut microbiota, modification of metabolic profiles, reinforcement of the intestinal barrier, and downregulation of the PI3K/AKT signaling pathway.


  • Open Access

    Bacillus amyloliquefaciens SC06 Ameliorated Intestinal Mucosal Injury by Regulated Intestinal Stem Cells Proliferation and Differentiation via Activating Wnt/β-Catenin Signal Pathway in Clostridium perfringens-Challenged Mouse

    by Hongbin Deng, Si Cheng, Jiemei Fan, Haibin Hao, Dandong Fang, Weiqin Li, Qi Wang

    The objective of our study was to verify the intervention effect of Bacillus amyloliquefaciens SC06 on NE by constructing a C. perfringens-induced intestinal damage mouse model. A total of 40 mice were randomly assigned to four treatments: CON (basal diet), CP (basal diet + C. perfringens), SC06 + CP (basal diet + SC06 + C. perfringens) and SC06 (basal diet + SC06). Our findings indicated that SC06 supplementation was effective in maintaining the integrity of the intestinal barrier, enhancing the antioxidant capacity of the intestine, reducing the generation of an inflammatory response, and suppressing enterocyte apoptosis in the presence of C. perfringens. Furthermore, SC06 supplementation enhanced the prefoliation of intestinal stem cells (ISC) and prompted their differentiation into goblet cells and Paneth cells. Moreover, our findings indicate that SC06 promotes the proliferation of C. perfringens-induced jejunum organoids and the expression of genes and proteins associated with ISC differentiation and regeneration. The mechanism by which SC06 modulates ISCs has been validated, and the results align with those obtained in vivo. In conclusion, the findings demonstrated that SC06 stimulates the proliferation and differentiation of ISCs through the activation of the Wnt/β-catenin signaling pathway, thereby accelerating epithelial regeneration and repair.